Pharmafile Logo
Pharmafocus logo
Advanced Search

Sales and Marketing

Showing 15 posts of 11524 posts found.

Veklury obtains FDA approval for COVID-19 outpatients

January 24, 2022 Sales and Marketing

The FDA has granted expedited approval of a supplemental new drug application (sNDA) for Veklury (remdesivir) for he treatment of …
News

Neurimmune and Ono Pharmaceutical collaborate to research neurodegenerative diseases

January 17, 2022 Sales and Marketing

Neurimmune AG has signed an expanded drug discovery collaboration agreement with Ono Pharmaceutical. The companies aim to focus on creating …
News

NICE draft guidance recommends new treatment for rare liver condition

January 17, 2022 Sales and Marketing

On Friday 14 January, NICE published a final draft Highly Specialised Technologies guidance, recommending odevixibat in line with its marketing …
News

FDA places Alzheimer’s therapeutic IND Application on hold

January 17, 2022 Sales and Marketing

The FDA has placed a hold on the Investigational New Drug (IND) application for DNL919, indicating they will provide an …
News

COVID-19 self-isolation cut to five full days in England

January 17, 2022 Sales and Marketing

The minimum self-isolation period for people testing positive for COVID-19 in England has been cut from seven days to five …
News

Trial finds new CAR T-cell therapy is effective at killing cancer cells

January 10, 2022 Sales and Marketing

A Phase I clinical trial funded by the NIHR Invention for Innovation (i4i) programme, and supported by the NIHR UCLH …
News

European Commission approves Lumykras for lung cancer patients

January 10, 2022 Sales and Marketing

The European Commission (EC) has granted conditional marketing authorisation for Lyumykras (sotorasib), a first-in-class KRAS inhibitor, for the treatment of …
News

FDA approval of QUVIVIQ (daridorexant) for the treatment of insomnia

January 10, 2022 Sales and Marketing

Idorsia Ltd has announced the FDA approval of QUVIVIQ™ (daridorexant) 25 mg and 50 mg for the treatment of adult …
News

Phase III trial into lebrikizumab shows positive results for atopic dermatitis patients

January 10, 2022 Sales and Marketing

Almirall has reported positive results from their Phase III trial into lebrikizumab, which demonstrated significant improvement and itch relief when …
News

Positive CHMP opinion for sickle cell disease anaemia tablet

December 20, 2021 Sales and Marketing

Global Blood Therapeutics (GBT) have announced the CHMP adopted a positive opinion recommending marketing authorisation for Oxbryta®  (vocelotor) tablets. Oxbryta …
News

FDA approval of Tezspire for severe asthma

December 20, 2021 Sales and Marketing

Tezpire (tezepelumab-ekko), manufactured by AstraZeneca and Amgen, has been approved in the US for the add-on maintenance treatment of adult …
News

Study reveals potential link between COVID-19 and Parkinson’s Disease

December 20, 2021 Sales and Marketing

Scientists in The Netherlands have detailed a possible correlation between COVID-19 and the onset of Parkinson’s disease. The findings may …
News

New COVID-19 drug Sotrovimab becomes available on NHS

December 20, 2021 Sales and Marketing

Sotrovimab, commercially known as Xevudy, is now available on the NHS to reduce the risk of vulnerable patients needing hospitalisation …
News
chris_hewitt_head_shot

Amarin appoints Dr Chris Hewitt UK and Ireland Medical Director

December 13, 2021 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing

Amarin has appointed Dr Chris Hewitt as UK and Ireland Medical Director. Hewitt is a UK-trained physician with many years …
Appointment
credit_-_crevis_shutterstock_340710245_720

CAR-T therapy trials show promise for earlier use in lymphoma

December 13, 2021 Sales and Marketing

Earlier use of chimeric antigen receptor (CAR) T-cell therapy for relapse B-cell lymphoma has demonstrated efficacy at substantially improving outcomes …
News
The Gateway to Local Adoption Series

Latest content

Siemens Healthineers opens 10m euro R&D centre for laboratory equipment in Ireland

February 19, 2026

Everdrone announces new board of directors to drive expansion

February 19, 2026

Regeneron announces presentations of new data on Eylea HD for retinal disease

February 18, 2026

Indegene completes acquisition of Cake Health

February 18, 2026

Gedeon Richter UK acquires rights to schizophrenia treatment Reagila from Recordati Pharmaceuticals

February 17, 2026